<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57-vaccines-07-00179">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>de Freitas</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Higa</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Sacramento</surname>
    <given-names>C.Q.</given-names>
   </name>
   <name>
    <surname>Ferreira</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Reis</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Delvecchio</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Monteiro</surname>
    <given-names>F.L.</given-names>
   </name>
   <name>
    <surname>Barbosa-Lima</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>James Westgarth</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Vieira</surname>
    <given-names>Y.R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo</article-title>
  <source>PLoS Negl. Trop. Dis.</source>
  <year>2019</year>
  <volume>13</volume>
  <elocation-id>e0007072</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pntd.0007072</pub-id>
  <?supplied-pmid 30699122?>
  <pub-id pub-id-type="pmid">30699122</pub-id>
 </element-citation>
</ref>
